Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Antigenics to Report First Quarter 2006 Financial Results on May 3, 2006; Conference Call to Follow.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- Antigenics Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:AGEN) will release its first quarter financial results before the market opens on May 3, 2006.

Antigenics executives will host a conference call at 11:00 a.m. ET that same day. To access the live call, dial 888-271-9082 (domestic) or 706-679-7741 (international); the access code is 8085047. The call will also be webcast and will be accessible from the company's website at www.antigenics.com/webcast/. A replay will be available approximately two hours after the call through midnight ET on May 17, 2006. The replay number is 800-642-1687 (domestic) or 706-645-9291 (international), and the access code is 8085047. The replay will also be available on the company's website approximately two hours after the live call.

Antigenics is a biotechnology company developing treatments for cancers, infectious diseases infectious diseases: see communicable diseases.  and autoimmune disorders Autoimmune Disorders Definition

Autoimmune disorders are conditions in which a person's immune system attacks the body's own cells, causing tissue destruction.
. For more information, please visit www.antigenics.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 25, 2006
Words:144
Previous Article:Former Barrick Gold Senior Project Geologist Joins Paramount Gold's Management Team.
Next Article:Bruker Daltonics Obtains Russian Medical Device Registration for all Flex(TM)-Series MALDI-TOF Mass Spectrometers.



Related Articles
Antigenics Reports First Quarter 2004 Financial Results and Recent Highlights.
Antigenics Reports Third Quarter 2005 Financial Results and Recent Highlights.
Antigenics Reports Phase 3 Results for Oncophage in Kidney Cancer; Study Did Not Meet Endpoints; Number of Events Insufficient for Analysis.
Antigenics Reports First Quarter 2006 Financial Results.
Antigenics Announces Results from In-Depth Analysis of Phase 3 Data of Oncophage in Kidney Cancer and Provides Regulatory Update.
Antigenics Reports Second Quarter 2006 Financial Results.
Antigenics Reports Third Quarter 2006 Financial Results.
Antigenics Reports Fourth Quarter and Year-End 2006 Financial Results.
Antigenics Reports First Quarter 2007 Financial Results.
Oncophage(R) Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles